Benralizumab (Medi-563) is an interleukin-5 receptor alpha (IL-5Ralpha) directed cytolytic monoclonal antibody that induces direct, rapid and almost complete depletion of eosinophils by enhancing antibose-dependent cell-mediated cytotoxicity.
Purity:
>99.0%
CAS Number:
[1044511-01-4]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted